Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. NVDA
9. BLZE
10. NKE

Go back to Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Aldeyra Therapeutics (ALDX) Misses Q2 EPS by 3c

August 9, 2018 7:34 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.46), $0.03 worse than the analyst estimate of ($0.43).

"As our lead product candidate reproxalap has advanced to four late-stage clinical programs, our development pipeline continues to grow, and now features a number of novel compounds across multiple... More